As shown in Table 4, only baseline CD34+ cell counts on Day +4 (P-value = 0.002) and lymphoma diagnosis (plasma cell disorders versus lymphoma - P-value = 0.041) were significantly associated with apheresis success. This evidence concerns the gene CD34 and plasma cell neoplasm.